Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;25(7):313–322. doi: 10.1002/clc.4950250703

Prevention of coronary restenosis with radiation therapy: A review

Nabeel Hafeez 1,✉
PMCID: PMC6654142  PMID: 12109864

Abstract

The problem of restenosis after percutaneous transluminal coronary angioplasty remains the major limiting factor of the procedure. Over the last 10 years, investigators have been studying the use of radiation therapy for preventing restenosis after angioplasty or stent placement. Since radiotherapy has been proven in other cases to be effective in disrupting the cell cycle regulatory proteins and thereby slowing or stopping growth, it was decided to apply the same principle to neointimal hyperplasia. To review the data that have emerged regarding vascular radiation with an emphasis on irradiated stents, 65 articles were reviewed and both pre‐clinical and clinical experiments were included. Overall, studies with gamma and beta radiation show promising results. Endovascular gamma radiation has been shown effective in randomized trials, even at 3‐year follow‐up. Beta radiation is preferred because of greater safety and localization, and because it has also shown encouraging results in initial clinical trials, as well as in larger randomized studies. Consequently, the Federal Drug Administration has approved the use of both. In both types of endovascular brachytherapy, it seems the greater the dose, the better the initial response. Safety concerns include an increased incidence of late thrombosis and greater restenosis at margins. With irradiated stents, however, the situation is not as clear. At times, animal models have presented confusing results. These have ranged from significant suppression of hyperplasia to outright adverse effects of radiation on the vessel wall. While some clinical trials have been encouraging, others have not. Follow‐up of up to 1 year has been disappointing so far. Many issues, such as the “candy wrapper” effect and rebound hyperplasia, must be dealt with before this becomes a viable form of therapy. It has become clear that radiation therapy in this setting, while having potentially great benefits, can cause deleterious effects as well. However, the mixed bag of positive and negative results seen so far, and the attractiveness of stents or percutaneous transluminal coronary angioplasty being “restenosis‐proofed,” eventually is cause for cautious optimism.

Keywords: brachytherapy, stent, radiation, angioplasty, endovascular radiation, irradiated stent, neointimal hyperplasia

Full Text

The Full Text of this article is available as a PDF (66.7 KB).

References

  • 1. Li AN, Eigler NL, Litvack F, Whiting JS: Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy. Am Assoc Physicists in Medicine 1998; 25:1:20–27 [DOI] [PubMed] [Google Scholar]
  • 2. Teirstein PS: B‐radiation to reduce restenosis: Too little, too soon? Circulation 1997; 95:1095–1097 [DOI] [PubMed] [Google Scholar]
  • 3. Duggan DM, Coffey CW, Levit S: Dose distribution of a 32P impregnated stent: Comparison of theoretical calculations and measurements with radiochromic film. Int J Rad Onc Biol Phys 1998; 40:3, 713–720 [DOI] [PubMed] [Google Scholar]
  • 4. Carter, AJ, Laird JR, Bailey LR, Hoopes TG, Farb A, Fischell DR, Fischell R, Fischell TA, Virmani R: The effects of endovascular radiation from a B‐particle emitting stent in a porcine restenosis model: A dose response study. Circulation 1996; 94:2364–2368 [DOI] [PubMed] [Google Scholar]
  • 5. Fischell TA, Kharma BK, Fischell DR, Loges PG, Coffey CW, Duggan DM, Naftilan AJ: Low‐dose B‐particle emission from stent wire results in complete localized inhibition of smooth muscle cell proliferation. Circulation 1994; 90:2956–2963 [DOI] [PubMed] [Google Scholar]
  • 6. Topol EJ, Serruys PW: Frontiers in interventional cardiology. Circulation 1998; 98:1802–1820 [DOI] [PubMed] [Google Scholar]
  • 7. Van Der Giessen WJ, Serruys PW: B‐particle emitting stents radiate enthusiasm in the search for effective prevention of restenosis. Circulation 1996; 94:2358–2360 [DOI] [PubMed] [Google Scholar]
  • 8. Hehrlein C, Gollan C, Donges K, Metz J, Riessen R, Fehsenfeld P, von Hodenberg E, Kubler W: Low‐dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1996; 92:1570–1575 [DOI] [PubMed] [Google Scholar]
  • 9. Crocker I: Radiation therapy to prevent coronary artery restenosis. Sem Rad Oncology 1999; 9(2): 134–143 [DOI] [PubMed] [Google Scholar]
  • 10. Taylor AJ, Gorman PD, Farb A, Hoopes TG, Virmani R: Long termcoronary vascular response to 32P beta particle‐emitting stents in acanine model. Circulation 1999; 100:2366–2372 [DOI] [PubMed] [Google Scholar]
  • 11. Schwartz RS, Koval TM, Edwards WD: Effect of external beam radiation on neointimal hyperplasia after experimental coronary artery injury. J Am Coll Cardiol 1992; 19:1106–1113 [DOI] [PubMed] [Google Scholar]
  • 12. Mazur W, Ali MN, Khan MM, Dabaghi SF, DeFelice CA, Paradis P Jr, Butler EB, Wright AE, Fajardo LF, French BA, Raizner AE: High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon‐injured porcine model of restenosis: Angiographic, morphometric, and histopathologic analyses. Int J Rad Onc Bio Phys 1996; 36:777–788 [DOI] [PubMed] [Google Scholar]
  • 13. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J: Intracoronary radiation reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994; 23:1491–1498 [DOI] [PubMed] [Google Scholar]
  • 14. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J: Intracoronary radiation markedly reduces neointimal proliferation after balloon angioplasty in swine: Persistent benefit at six month follow‐up. J Am Coll Cardiol 1995; 25:1451–1456 [DOI] [PubMed] [Google Scholar]
  • 15. Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez J, Burger B, Villoria G, Acquatella H, Crocker IR, Seung KB, Liprie SF: Long‐term angiographic and clinical outcome after percutaneous transluminal angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96:727–732 [DOI] [PubMed] [Google Scholar]
  • 16. Teirstein PS, Massullo V, Jani S: Catheter‐based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336:1697–1703 [DOI] [PubMed] [Google Scholar]
  • 17. Teirstein PS, Massullo V, Jani S, Russo RJ, Cloutier DA, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Norman S, Tripuraneni P: Two‐year follow‐up after catheter‐based radiotherapy to inhibit coronary restenosis. Circulation 1999; 99:243–247 [DOI] [PubMed] [Google Scholar]
  • 18. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Clouter DA, Leon MB, Tripuraneni P: Three year clinical and angiographic follow‐up after intracoronary radiation. Results of a randomized clinical trial. Circulation 2000; 101:360–365 [DOI] [PubMed] [Google Scholar]
  • 19. Leon MB, Teirstein PS, Lansky AJ: Intracoronary gamma radiationto reduce in‐stent restenosis: The Multicenter Gamma I Randomized Clinical Trial. #77‐1. Presented at the American College of Cardiology: Interventional Symposium. March 7, New Orleans (as per Cardiology Today, July 1999)
  • 20. Waksman R, White LR, Chan RC, Bass BG, Geirlach L, Mintz GS, Satler LF, Mehran R, Serruys PW, Lansky AJ, Fitzgerald P, Bhargava B, Kent KM, Pichard AD, Leon MB: Intracoronary radiation therapy for patients with in‐stent restenosis: 6 Month follow‐up of a randomized clinical study. #3421. Presented at the American Heart Association's 71st Scientific Sessions. Nov. 8–11, Dallas (per Cardiol Today, Alexander W, Feb. 1999)
  • 21. Waksman R, Bargava B, Chan RC, Sherman W, Pisch J, Mintz GS, Lansky AJ, Ahmed J, Ricci NA, Liprie SF: Intracoronary radiation with gamma wire inhibits recurrent in‐stent restenosis. Cardio vasc Rad Med 2001; 2(2): 63–68 [DOI] [PubMed] [Google Scholar]
  • 22. Verin V, Urban P, Popowski Y, Schwager M, Nouet P, Dorsaz PA, Chatelain P, Kurtz JM, Rutishauser W: Feasibility of B‐irradiation to reduce restenosis after balloon angioplasty: A clinical pilot study. Circulation 1997; 95:1138–1144 [DOI] [PubMed] [Google Scholar]
  • 23. Robinson K, Pipes D, Van Bibber R: Dose‐response evaluation in balloon injured pig coronary arteries of a B‐emitting 186 Re liquid‐filled balloon catheter system for endovascular brachytherapy. Proc Adv Cardiovasc Rad Ther 1997; 7 [Google Scholar]; (from Crocker I: Coronary artery restenosis prevention. Sem Rad Oncol 1999; 9(2): 134–143) [DOI] [PubMed] [Google Scholar]
  • 24. King SB III, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, Macdonald J, Anderberg K, Crocker IR: Endovascular beta radiation to reduce restenosis after coronary balloon angioplasty: Results of the Beta Energy Restenosis Trial (BERT). Circulation 1998; 97:2025–2030 [DOI] [PubMed] [Google Scholar]
  • 25. Meerkin D, Tardiff JC, Crocker IR, Arsenault A, Joyal M, Lucier G, King SB, Williams DO, Serruys PW, Bonan R: Effects of B‐radiation therapy after coronary angioplasty. Circulation 1999; 99:1660–1669 [DOI] [PubMed] [Google Scholar]
  • 26. Kuntz R, Speiser B, Joyal M, Bonan R, Arseneault A, Neiss G, Cox D, Kirsch M, Laskey W, Suntharalingham M, Wilmer C, Brown C, Schwaibold F, Silber S, Von Rottkay P, Fischmann D, Savage M, Pocock S, Abdalla M: for the Beta‐Cath System Trial Investigators : Clinical and angiographic outcomes after use of Sr‐90 beta radiation for the treatment of de novo and restenotic coronary lesions. Presented at the 50th Scientific Session of the American College of Cardiology March 18, 2001.
  • 27. Raizner AE, Oesterle SN, Waksman R, Serruys PW, Colombo A, Lim YL, Yeung AC, van der Giessen WJ, Vandertie L, Chiu JK, White LR, Fitzgerald PJ, Kaluza GL, Ali NM: Inhibition of restenosis with beta‐emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation (Online). 2000; 102(9): 951–958 [DOI] [PubMed] [Google Scholar]
  • 28. Kay IP, Wardeh A, Kozuma K, Foley D, Knook AH, Thury A, Sianos G, Van Der Giessen W, Levendag P, Serruys P: Radioactive stents delay but do not prevent in‐stent neointimal hyperplasia. Circulation 2001; 103:14–17 [DOI] [PubMed] [Google Scholar]
  • 29. Waksman R: Vascular brachytherapy: Update on clinical trials. J In vas Cardiol 2000; 12(suppl A): 18A–28A [PubMed] [Google Scholar]
  • 30. Hoher M, Wohrle J, Wohlfrom M, Hanke H, Voisard R, Osterhues HH, Kochs M, Reske SN, Hombach V, Kotzerke J: Intracoronary beta‐irradiation with a liquid (188)re‐filled balloon: Six‐month results from a clinical safety and feasibility study. Circulation 2000; 101(20): 2355–2360 [DOI] [PubMed] [Google Scholar]
  • 31. Waksman R, Robinson KA, Crocker IR, Wang C, Gravanis MB, Cipolla GD, Hillstead RA, King SB III: Intracoronary low dose B‐irradiation inhibits neointimal formation after coronary artery balloon injury in the swine restenosis model. Circulation 1995; 92:3025–3031 [DOI] [PubMed] [Google Scholar]
  • 32. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, Seung KB, King SB III: Intracoronary radiation decreased the second phase of intimal hyperplasia in a repeat balloon angioplastymodel of restenosis. Int J Rad Onc Bio Phys 1997; 39:475–80 [DOI] [PubMed] [Google Scholar]
  • 33. Waksman R, White LR, Chan RC, Mintz GS, Satler LF, Mehran R, Lansky AJ, Bhargava B, Kent KM, Pichard AD, Leon MB: Intracoronary beta‐radiation therapy inhibits recurrence of in‐stent restenosis. Circulation 2000; 101(16): 1895–1898 [DOI] [PubMed] [Google Scholar]
  • 34. Rubin P, Williams JP, Riggs PN, Bartos S, Sarac T, Pomerantz R, Castano J, Schell M, Green RM: Cellular and molecular mechanisms of radiation inhibition of restenosis. IntJ Rad Onc Biol Phys 1998; 40:929–941 [DOI] [PubMed] [Google Scholar]
  • 35. Saperstein W, Zuckerman B, Dillard J: FDA approval of coronary‐artery brachytherapy. N Engl J Med 2001; 344(4): 297–299 [DOI] [PubMed] [Google Scholar]
  • 36. Kim HS, Waksman R, Cottin Y, Kollum M, Bhargava B, Mehran R, Chan RC, Mintz GS: Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in‐stent restenosis. J Am Coll Cardiol 2001; 37(4): 1026–1030 [DOI] [PubMed] [Google Scholar]
  • 37. Leon MB, Teirstein PS, Moses JW: Localized intracoronary gamma radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344(4): 250–256 [DOI] [PubMed] [Google Scholar]
  • 38. The CAPTURE Investigators : Randomized placebo‐controlled trial of abciximab before and during intervention in refractory unstable angina: The CAPTURE Study. Lancet 1997; 349:1429–1435 [PubMed] [Google Scholar]
  • 39. The RESTORE Investigators : Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997; 96:1445–1453 [DOI] [PubMed] [Google Scholar]
  • 40. Serruys PW, De Jaegere P, Kiemeneiji F, Macaya C, Rutsch W, Heyndrickx G, Emanuelson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy J, Van Den Heuval P, Delcan J, Morel MA, for the Benestent Study Group : A comparison of balloon‐expandable‐stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331:489–495 [DOI] [PubMed] [Google Scholar]
  • 41. Laird JR, Carter AJ, Kufs W, Hoopes TG, Farb A, Nott S, Fischell R, Fischell D, Virmani R, Fischell T: An inhibition of neointimal proliferation with a beta particle emitting stent. Circulation 1996; 93:529–536 [DOI] [PubMed] [Google Scholar]
  • 42. Heirlein C, Stintz M, Kinscherf R, Schlosser K, Huttel E, Friedrich L, Fehsenfeld P, Kubler W: Pure B‐particle emitting stents inhibit neointima formation in rabbits. Circulation 1996; 93:641–645 [DOI] [PubMed] [Google Scholar]
  • 43. Carter AJ, Fischell TA: Current status of radioactive stents for the prevention of in‐stent restenosis. Int J Rad Onc Biol Phys 1998; 41:1, 127–133 [DOI] [PubMed] [Google Scholar]
  • 44. Carter AJ, Scott D, Baily LR: High activity 32P stents promote the development of atherosclerosis at six months in a porcine coronary model. Circulation 1997; 96(suppl‐I): I‐607 [Google Scholar]
  • 45. Baim D, Fischell T, Weismann N: Short‐term (1 month) results of the IRIS feasibility study of beta particle emitting radioisotope stent. Circulation 1997; 96(suppl): 1206 [Google Scholar]
  • 46. Carter AJ, Scott D, Bailey L, Hoopes T, Jones R, Virmani R: Dose‐response effects of 32P radioactive stents in an atherosclerotic porcine coronary model. Circulation 1999; 100:1548–1554 [DOI] [PubMed] [Google Scholar]
  • 47. Albiero R, Adamian M, Kobayashi N, Amato A, Vaghetti M, Di Mario C, Colombo A: Short and intermediate‐term results of 32P radioactive beta‐emitting stent implantation in patients with coronary artery disease. The Milan Dose‐Response Study. Circulation 2000; 101:18–26 [DOI] [PubMed] [Google Scholar]
  • 48. Albiero R, Takahiro N, Adamian M, Amato A, Vaghetti M, Nicola C, Di Mario C, Colombo A: Edge restenosis after implantation of high activity 32P radioactive beta‐emitting stents. Circulation 2000; 101:2454–2457 [DOI] [PubMed] [Google Scholar]
  • 49. Serruys PW, Kay P: I like the candy, I hate the wrapper. Circulation 2000; 101:3–7 [DOI] [PubMed] [Google Scholar]
  • 50. Kozuma K, Costa M, Sabate M, Kay P, Marijnissen J, Coen V, Serrano P, Ligthart J, Levendag P, Serruys P: Three‐dimensional in‐travascular ultrasound assessment of noninjured edges of beta‐irradiated coronary segments. Circulation 2000; 102:1484–1489 [DOI] [PubMed] [Google Scholar]
  • 51. Kay IP, Wardeh A, Kozuma K, Foley D, Knook AH, Thury A, Sianos G, Van Der Giessen W, Levendag P, Serruys P: Radioactivestents delay but do not prevent in‐stent neointimal hyperplasia. Circulation 2001; 103:14–17 [DOI] [PubMed] [Google Scholar]
  • 52. Alt E, Herrmann RA, Rybnikar A, Knebel JB, Ritscher G, Markl B, Hausleiter J, Wolf I, Erhard W, Schwaiger M, Schomig A: Reduction of neointimal proliferation after implantation of a beta particle emitting gold Au 198 coated stent (abstr). J Am Coll Cardiol 1998; 31(2 suppl A, ): 350A [Google Scholar]
  • 53. Schulz C, Niederer C, Andres C, Herrman RA, Panzer W, Herrman C, Wolf I, Alt E: Intracoronary radiation using a beta‐particle emitting gold stent increases neointima formation in a porcine coronaryrestenosis model (abstr). Am Coll Cardiol 1999; 33:21A [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES